Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
05/2002
05/30/2002CA2429712A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/30/2002CA2429699A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/30/2002CA2398924A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
05/30/2002CA2364123A1 Solitary bee nesting block
05/30/2002CA2363951A1 Modulating ramp activity
05/29/2002EP1208384A2 Methods and compositions for modulating oxidized ldl transport
05/29/2002EP1208216A2 Fatty acid desaturase gene from plants
05/29/2002EP1208200A2 Transgenic animal model for neurodegenerative diseases
05/29/2002EP1208194A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
05/29/2002EP1208112A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
05/29/2002EP1208111A2 Genes encoding insect odorant receptors and uses thereof
05/29/2002EP1207751A1 Non-mammalian transgenic animal model for cellular proliferative diseases
05/29/2002CN1351666A Recombinant bacterial phytases and uses thereof
05/29/2002CN1351484A Compositions for freezing dog sperm, method of freezing the dog sperm utilizing the compositions and artificial insemination method employing the frozen dog sperm
05/29/2002CN1350778A Method for producing non-natural silk with silkworm
05/29/2002CN1085488C Tech of breeding tetrastichidae by utilizing tussah chrysalis
05/28/2002US6395961 Gene transfer in chickens by introduction of DNA into muscle in ovo
05/28/2002US6395960 A genetically engineered rodent; diagnosis and therapy for alzheimer's disease
05/28/2002US6395959 Nucleotide sequence encoding the enzyme I SceI and the use thereof
05/28/2002US6395530 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
05/28/2002US6395511 Nuclelotide sequences coding regulatory protein; for usein treatment of bone disorders
05/28/2002US6395487 Deleting, duplicating or inverting segments of chromosomes; obtain cells, transform, recover cells expressing preferential markers
05/28/2002CA2181377C Tetracyclic derivatives, process of preparation and use
05/23/2002WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
05/23/2002WO2002040683A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/23/2002WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same
05/23/2002WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
05/23/2002WO2002040528A1 A method of producing non-natural silk by bombyx mori
05/23/2002WO2002040061A2 Immunocompetent animals including xenogeneic implants of mesenchymal stem cells
05/23/2002WO2002016559A8 In vivo animal model of human leukemia
05/23/2002WO2002015931A9 Immunologic method for the prevention of dental caries
05/23/2002WO2002004609A3 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
05/23/2002WO2002003911B1 Prevention and treatment of alzheimer's disease
05/23/2002WO2001095716A3 High temperature cryogenic preservation of biologically active material
05/23/2002WO2001085151A3 Chimeric animal model and treatment of psoriasis
05/23/2002WO2001064837A8 β NETRIN AND USES THEREOF
05/23/2002US20020062493 For general parasite resistance, including insect, fungi, virus, bacteria, and mites
05/23/2002US20020062491 Method of producing primary hepatocellular carcinoma-bearing model animals
05/23/2002US20020062490 Transgenic animal for use in the treatment of blood pressure defects
05/23/2002US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
05/23/2002US20020061587 Treating cardiovascular disorders and tissue; obtain tissue, incubate with cytokines, graft somatic stem cells, monitor tissue adjustment in activity
05/23/2002US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents
05/23/2002US20020061545 Streptococcus pneumoniae antigens and vaccines
05/23/2002US20020061295 Myocardial grafts and cellular compositions useful for same
05/23/2002CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
05/23/2002CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same
05/23/2002CA2428850A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/23/2002CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
05/22/2002EP1207200A1 High affinity choline transporter
05/22/2002EP1206537A2 Nucleic acids and polypeptides of invertebrate twik channels and methods of use
05/22/2002EP1206479A1 A polynucleotide encoding a human junctional adhesion protein (jam-2)
05/22/2002EP1206178A1 A large animal model of invasive pulmonary aspergillosis in an immunocompromised host
05/22/2002EP0437599B1 Cell lineages expressing a biologically active factor ix
05/21/2002US6392118 Stable cultures; for controlling cell distribution within artificial organ
05/21/2002US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
05/21/2002US6392024 Nucleotide sequences coding freeze resistant polypeptide; for use in food processing and organ transplants
05/21/2002US6391606 Peptides; for use in the develoment of human diagnostic and therapeutic agents
05/21/2002US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects
05/21/2002US6391553 Analyzing level of gene expression of epsilon 4 or epsilon 2 alleles of apolipoprotein e; mutation in consensus sequence binding a transcription factor and either increase in epsilon 4 or decrease in epsilon 2 indicate disease
05/21/2002US6391547 Microbial β-glucuronidase genes, gene products and uses thereof
05/21/2002US6390821 Phosphorylation
05/16/2002WO2002038752A2 Use of a helminth for the in vivo delivery of a medicament
05/16/2002WO2002038751A2 Ras/p21 transgenic mouse
05/16/2002WO2002038748A2 Mammalian sex selection using genetic modification
05/16/2002WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
05/16/2002WO2002038108A2 Methods of treating disorders related to apoe
05/16/2002WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/16/2002WO2001090313A3 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
05/16/2002WO2001088098A3 Fertilization of aged oocytes
05/16/2002WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene
05/16/2002WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/16/2002WO2001032685A8 Gene expression directed by a super-psa promoter
05/16/2002WO2001029255A3 Diagnostic test for cephalic pain
05/16/2002US20020058970 Animal model system for artificially inducing a heart arrhythmia
05/16/2002US20020058267 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease
05/16/2002US20020058036 Novel fibroblast growth factor and nucleic acids encoding same
05/16/2002CA2433200A1 Use of a helminth for the in vivo delivery of a medicament
05/16/2002CA2428326A1 Mammalian sex selection using genetic modification
05/16/2002CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
05/16/2002CA2426030A1 Methods of treating disorders related to apoe
05/15/2002EP1205766A1 Method and device for recording polarized electromagnetic radiation of inactivated strain of pathogenic microorganisms onto a crystal, method and device for changing activity of strain of pathogenic microorganisms, method for eliminating strain of pathogenic microorganisms from human or animal organism
05/15/2002EP1204760A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy
05/15/2002EP1204757A1 Neutral cerebral-sphingomyelinase
05/15/2002EP1204747A1 G protein-coupled receptor expressed in brain
05/14/2002US6388064 Human 2-19 protein homologue, z219a
05/14/2002US6388055 Mouse CC-CKR5 receptor polypeptide
05/14/2002US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents
05/14/2002US6387616 Torsin, torsin genes, and methods of use
05/10/2002WO2002036789A2 Methods of modifying eukaryotic cells
05/10/2002WO2002036784A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation
05/10/2002WO2002036771A2 Imaging, diagnosis and treatment of disease
05/10/2002WO2002036770A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
05/10/2002WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
05/10/2002WO2002035923A1 Hypertension
05/10/2002WO2002009641A3 Promyostatin peptides and methods of using same
05/10/2002WO2001093669A3 Compound screens relating to insulin deficiency or insulin resistance
05/10/2002WO2001088116A3 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
05/10/2002WO2001070808A3 Angiogenesis - associated proteins, and nucleic acids encoding the same
05/10/2002WO2001066742A3 G-protein coupled receptors
05/10/2002WO2001042451A3 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS